Positions

Principal Investigator On

Investigator On

  • A Phase 2 Proof-of-concept Study to Evaluate the Efficacy and Safety of MEDI3902 in Mechanically Ventilated Patients for the Prevention of Nosocomial Pneumonia Caused by Pseudomonas aeruginosa  awarded by DUKE CLINICAL RESEARCH INSTITUTE
  • Consortium on Resistance Against Carbapenems in Klebsiella pneumoniae and Other Enterobacteriaceae (CRACKLE): a Prospective, Observational Cohort Study  awarded by Duke University
  • Dalbavancin as an Option for Treatment of S. aureus Bacteremia (DOTS): A Phase 2b, Multicenter, Randomized, Open-Label, Assessor-Blinded Superiority Study to Compare the Efficacy and Safety of Dalbavancin to Standard of Care Antibiotic Therapy for the Completion of Treatment of Patients with Complicated S. aureus Bacteremia  awarded by Duke University
  • High VS. Standard Dose Flu Vaccine in Adult Stem Cell Transplant Recipients  awarded by VANDERBILT UNIVERSITY
  • Kaizen-ME: A Novel Gamification-lnfused Education Platform for Millennial Learners  awarded by UNIVERSITY OF ALABAMA HEALTH SERVICES FOUNDATION
  • Leadership Group for the Infectious Diseases Clinical Research Consortium (IDCRCLG) COVID 19 SUPPLEMENT  awarded by Emory University
  • Private Grant  awarded by T2 BIOSYSTEMS
  • Private Grant  awarded by CEREXA, INC.
  • Private Grant  awarded by MERCK SHARP & DOHME CORP
  • Private Grant  awarded by T2 BIOSYSTEMS
  • Private Grant  awarded by SCYNEXIS
  • Private Grant  awarded by IMMUNO-MYCOLOGICS, INC.
  • Private Grant  awarded by T2 BIOSYSTEMS
  • Private Grant  awarded by CIDARA THERAPEUTICS, INC. - NEW
  • Private Grant  awarded by SCYNEXIS
  • Private Grant  awarded by MAYNE PHARMA INC
  • Private Grant  awarded by AMPLYX PHARMACEUTICALS INC
  • Private Grant  awarded by CIDARA THERAPEUTICS, INC. - NEW
  • Private Grant  awarded by HOOKIPA BIOTECH
  • Private Grant  awarded by CIDARA THERAPEUTICS, INC. - NEW
  • Prospective Observational Evaluation of the Association Between the Day 2 Vancomycin Exposure and Failure Rates Among Adult Hospitalized Patients with MRSA Bloodstream Infections (PROVIDE)  awarded by Duke University
  • The Natural History of Antifungal Failure in Invasive Candidiasis in the United States  awarded by UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER (HOUSTON)
  • UAB Public Health/Biomedical Research Training Program  awarded by NATIONAL INSTITUTE ON MINORITY HEALTH AND HEALTH DISPARITIES/NIH/DHHS

    • Education And Training

  • UAB Hospital, Residency
  • Massachusetts General Hospital, Postdoctoral Fellowship
  • Doctor of Medicine, 1998

    • Full Name

  • Martin Rodriguez